PMA device
Ladarvision 4000 Excimer Laser System and the Ladar 6000 Excimer Laser System
Alcon Laboratories · Excimer Laser System (LZS, Class III) · First FDA decision Oct 18, 2002, newest Jul 5, 2006Nearsightedness and refractive error
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
1
Naming "Ladarvision 4000"
MAUDE reports
0
Brand "Ladarvision 4000", since 2015
PubMed studies
19
Mentioning "Ladarvision 4000"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ladarvision 4000 Excimer Laser System and the Ladar 6000 Excimer Laser System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
P970043-S025 · Decided Jul 5, 2006 · 154 days after receipt · Normal 180 Day Track
Device type: Excimer laser system (LZS) · Ophthalmology
P970043-S022 · Decided May 2, 2006 · 180 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
- LADARVISION 4000 EXCIMER LASER SYSTEMPMA supplement
P970043-S020 · Decided May 1, 2006 · 339 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ladarvision 4000", any status and sponsor, newest update first.
Durrie VisionAcademic, hospital or other
NCT00821236 · 40 participants · Start Jan 2009 · Primary completion Feb 2010
Device: Excimer Laser; AMO/VISX CustomVue™ and 1 more · For: Myopia; Astigmatism
Sites: Overland Park, Kansas; Greensboro, North Carolina
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ladarvision 4000", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LZS
7,603 reports: 949 malfunction, 6,624 injury, 12 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- LADAR6000 Excimer Laser SystemTerminated
Alcon Refractive Horizons, Inc.
Z-0854-2007 · Started Feb 21, 2007 · Posted by FDA Jun 5, 2007
Reason given: Observed 'central islands' in patients following custom myopia laser procedures using the LADAR6000 Excimer Laser. (On May 11, 2007, Alcon notified consignees that the device software programs for CustomCornea Myopia and CustomCornea Myopia with Astigmatism of the device would be deactivated)
Cause as FDA categorized it: Other · Device type: Excimer Laser System (LZS)
- LADARVision Excimer Laser System.Terminated
Z-1147-06 · Started Aug 1, 2005 · Posted by FDA Jun 21, 2006
Reason given: Alcon has identified a software error associated with the use of the Measuring Mode (ruler tool) on the LADARVision4000 Excimer Laser Systems. Use of this feature after alignment of the horizontal reference line will negate compensation for cyclotorsion on CustomCornea procedures, possibly adversely affecting clinical...
Cause as FDA categorized it: Other · Device type: Excimer Laser System (LZS)
Published research
The most relevant PubMed records for "Ladarvision 4000"[tiab]. The summary above synthesizes these.
- Laser in situ keratomileusis using the Nidek EC-5000 or the Alcon LADARVision 4000 systems.
Fraunfelder FW, Rich LF · J Refract Surg · 2004Comparative Study, Research Support, Non-U.S. Gov't
- Effect of optical zone ablation diameter on LASIK-induced higher order optical aberrations.
Mok KH, Lee VW · J Refract Surg · 2005Comparative Study
- Comparative study of ablation profiles of six different excimer lasers.
Canals M, Elies D, Costa-Vila J, et al. · J Refract Surg · 2004Comparative Study
- Retrospective comparison of 3 laser platforms to correct myopic spheres and spherocylinders using conventional and wavefront-guided treatments.
Binder PS, Rosenshein J · J Cataract Refract Surg · 2007Comparative Study
- Laser in situ keratomileusis for hyperopia with the LADARVision 4000 with centration on the coaxially sighted corneal light reflex.
Nepomuceno RL, Boxer BS, Wachler, et al. · J Cataract Refract Surg · 2004
- Wavefront-guided refractive surgery results of training-surgeons.
Stillitano I, Yamazaki E, Melo LA, et al. · Arq Bras Oftalmol · 2010
- Monovision laser in situ keratomileusis for pre-presbyopic and presbyopic patients.
Miranda D, Krueger RR · J Refract Surg · 2004
- Nomogram adjustment of laser in situ keratomileusis for myopia and myopic astigmatism with the Alcon LADARVision system.
Caster AI, Hoff JL, Ruiz R · J Refract Surg · 2004
- Development of an advanced nomogram for myopic astigmatic wavefront-guided laser in situ keratomileusis (LASIK).
Biebesheimer JB, Kang TS, Huang CY, et al. · Ophthalmic Surg Lasers Imaging · 2011
- Two-step laser in situ keratomileusis to correct high astigmatism after corneal autograft.
Colin J, Abdelkefi A · J Cataract Refract Surg · 2006Case Reports
- Visual field changes after laser in situ keratomileusis.
Brown SM, Bradley JC, Xu KT, et al. · J Cataract Refract Surg · 2005Clinical Trial, Research Support, Non-U.S. Gov't
- The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia.
Sia RK, Ryan DS, Edwards JD, et al. · J Refract Surg · 2014Comparative Study, Randomized Controlled Trial
Other devices of this type
Also filed under product code LZS.
- WaveLight EX500 LaserAlcon Laboratories, Inc. · PMA 2025
- Wavelight Allegretto Wave Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2013
- STAR S4 IR Excimer Laser System and iDESIGN Refractive StudioAmo Manufacturing USA, LLC · PMA 2019
- Nidek EC-5000 Excimer Laser SystemNidek Co., Ltd. · PMA 2018
- Bausch & Lomb Technolas T217Z Zyoptix Laser SystemTechnolas Perfect Vision GmbH · PMA 2010
- Allegretto Wave Eye-Q Excimer Laser SystemAlcon Laboratories, Inc. · PMA 2015
- Technolas 217A Excimer Laser SystemTechnolas Perfect Vision GmbH · PMA 2003
- iDESIGN Refractive Studio, STAR S4 IR Excimer Laser SystemAmo Manufacturing USA, LLC · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.